Variant report
Variant | nsv1041271 |
---|---|
Chromosome Location | chr10:56955923-56999843 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs532055315 | chr10:56961406-56961407 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs187320859 | chr10:56961415-56961416 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs562357924 | chr10:56961446-56961447 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs527719287 | chr10:56961454-56961455 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs16907109 | chr10:56961460-56961461 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs2166153 | chr10:56961505-56961506 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs192575654 | chr10:56961518-56961519 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs555184071 | chr10:56961557-56961558 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs141623364 | chr10:56961560-56961561 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs573488069 | chr10:56961563-56961564 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs573479937 | chr10:56961565-56961566 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs372646832 | chr10:56961631-56961632 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs535266241 | chr10:56961685-56961686 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs538031550 | chr10:56961691-56961692 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs146992717 | chr10:56961712-56961713 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs540958678 | chr10:56961731-56961732 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs571994394 | chr10:56961742-56961743 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs184598407 | chr10:56961754-56961755 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs534344572 | chr10:56961823-56961824 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs188171095 | chr10:56961838-56961839 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs577686451 | chr10:56961866-56961867 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs543112726 | chr10:56961868-56961869 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs192174576 | chr10:56961890-56961891 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs576749681 | chr10:56961906-56961907 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs34663271 | chr10:56961936-56961937 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs147612237 | chr10:56961963-56961964 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs142313333 | chr10:56961987-56961988 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs527958974 | chr10:56962009-56962010 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs547785326 | chr10:56962012-56962013 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs539342436 | chr10:56962013-56962014 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs564282061 | chr10:56962027-56962028 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs533468361 | chr10:56962031-56962032 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs184438112 | chr10:56962111-56962112 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs569807727 | chr10:56962156-56962157 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs35615819 | chr10:56962207-56962208 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs535301246 | chr10:56962209-56962210 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs143190755 | chr10:56962235-56962236 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs148264222 | chr10:56962265-56962266 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs534582296 | chr10:56962266-56962267 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs73265590 | chr10:56962293-56962294 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs141162740 | chr10:56962311-56962312 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs189694843 | chr10:56962359-56962360 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs533380661 | chr10:56962361-56962362 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs556812420 | chr10:56962371-56962372 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs181235384 | chr10:56962377-56962378 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs150291471 | chr10:56962405-56962406 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs555959365 | chr10:56962406-56962407 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs572786793 | chr10:56962408-56962409 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs545025377 | chr10:56962433-56962434 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs563695798 | chr10:56962466-56962467 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Pancreatic endocrine tumor | 17639061 | CNVD |
Gastric cancer | 17908304 | CNVD |
Chordoma | 21602918 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Melanoma | 18172304 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Acute lymphoblastic leukemia | 20724749 | CNVD |
Autism | 22495311 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Prostate cancer | 18632612 | CNVD |
Autism | 18414403 | CNVD |
Cockayne syndrome | 18421352 | CNVD |
Glioblastoma | 16823260 | CNVD |
Medulloblastoma | 16968546 | CNVD |
Neuroblastoma | 17533364 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Glioma | 21971842 | CNVD |
Cancer | 21637783 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Obesity | 21956041 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 21364760 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Autism | 20841430 | CNVD |
Mental retardation | 17124404 | CNVD |
Epilepsy | 20923578 | CNVD |
Prostate cancer | 16573809 | CNVD |
Schizophrenia | 19329560 | CNVD |
Heart failure | 18772530 | CNVD |
Heart failure | 18854381 | CNVD |
Hyperglycemia | 19060297 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Usher syndrome | 20538994 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
Autism | 20858243 | CNVD |
Breast cancer | 22522925 | CNVD |
Usher type I cohort | 17277737 | CNVD |
Usher type I cohort | 21436283 | CNVD |
Leukemia | 21357790 | CNVD |
Medulloblastoma | 22832581 | CNVD |
small cell lung cancer | 17426248 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
Non-syndromic sensorineural hearing loss | 21293372 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr10:56961400-56961800 | Enhancers | Fetal Stomach | stomach |
2 | chr10:56961800-56962200 | Weak transcription | Fetal Stomach | stomach |
3 | chr10:56962200-56962400 | Enhancers | Fetal Stomach | stomach |
4 | chr10:56962400-56963400 | Weak transcription | Fetal Stomach | stomach |
5 | chr10:56963600-56963800 | Enhancers | Fetal Stomach | stomach |
6 | chr10:56977800-56978400 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
7 | chr10:56992200-56993600 | Active TSS | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
8 | chr10:56992400-56992600 | Enhancers | GM12878-XiMat | blood |
9 | chr10:56992400-56992600 | Enhancers | Hela-S3 | cervix |
10 | chr10:56992400-56992800 | Active TSS | Stomach Smooth Muscle | stomach |
11 | chr10:56992400-56993400 | Active TSS | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
12 | chr10:56992400-56993400 | Active TSS | Duodenum Mucosa | Duodenum |
13 | chr10:56992600-56993000 | Enhancers | Liver | Liver |
14 | chr10:56992600-56993400 | Active TSS | GM12878-XiMat | blood |
15 | chr10:56992800-56993200 | Active TSS | Rectal Mucosa Donor 29 | rectum |
16 | chr10:56993000-56993400 | Active TSS | Duodenum Smooth Muscle | Duodenum |
17 | chr10:56993000-56993600 | Active TSS | Liver | Liver |
18 | chr10:56998800-56999800 | Enhancers | HUES64 Cell Line | embryonic stem cell |
19 | chr10:56999200-56999600 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
20 | chr10:56999200-57000000 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
21 | chr10:56999800-57002200 | Weak transcription | HUES64 Cell Line | embryonic stem cell |